A Maryland University spinout is working on portable artificial lungs after gaining the rights to the technology and receiving a $100,000 investment.
Breethe, a Maryland University spinout that has created a portable lung, has received approval to licence its technology.
UM Ventures, the university’s commercialisation office, provided the company with permission to licence the technology it had developed. Breethe has the exclusive rights to this technology.
The system is a wearble, backpack-sized device that oxygenates the blood, acting as an artificial lung for patients that would usually be restricted to a respirator in a hospital.
Phil Robilotto, chief commercialisation officer, UM Ventures, said: “The portable artificial lung system developed at University of Maryland School of Medicine has the potential to revolutionise treatment for patients with severe pulmonary disease. Breethe has quickly assembled a superior management team and UM Ventures is excited to see the company advance this extremely promising technology to the medical market place.”
Lung Disease in the US is responsible for one in six deaths.
UM Venture invested $100,000 in Breethe.
